Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Detalles Bibliográficos
Autores principales: Decraene, Brecht, Yang, Yihan, De Smet, Frederik, Garg, Abhishek D., Agostinis, Patrizia, De Vleeschouwer, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758048/
https://www.ncbi.nlm.nih.gov/pubmed/36333555
http://dx.doi.org/10.1038/s41435-022-00187-3
_version_ 1784851956729118720
author Decraene, Brecht
Yang, Yihan
De Smet, Frederik
Garg, Abhishek D.
Agostinis, Patrizia
De Vleeschouwer, Steven
author_facet Decraene, Brecht
Yang, Yihan
De Smet, Frederik
Garg, Abhishek D.
Agostinis, Patrizia
De Vleeschouwer, Steven
author_sort Decraene, Brecht
collection PubMed
description
format Online
Article
Text
id pubmed-9758048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97580482022-12-18 Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma Decraene, Brecht Yang, Yihan De Smet, Frederik Garg, Abhishek D. Agostinis, Patrizia De Vleeschouwer, Steven Genes Immun Correction Nature Publishing Group UK 2022-11-04 2022 /pmc/articles/PMC9758048/ /pubmed/36333555 http://dx.doi.org/10.1038/s41435-022-00187-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Decraene, Brecht
Yang, Yihan
De Smet, Frederik
Garg, Abhishek D.
Agostinis, Patrizia
De Vleeschouwer, Steven
Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title_full Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title_fullStr Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title_full_unstemmed Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title_short Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
title_sort publisher correction: immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758048/
https://www.ncbi.nlm.nih.gov/pubmed/36333555
http://dx.doi.org/10.1038/s41435-022-00187-3
work_keys_str_mv AT decraenebrecht publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma
AT yangyihan publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma
AT desmetfrederik publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma
AT gargabhishekd publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma
AT agostinispatrizia publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma
AT devleeschouwersteven publishercorrectionimmunogeniccelldeathanditstherapeuticorprognosticpotentialinhighgradeglioma

Ejemplares similares